Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile
Open Access
- 4 April 2013
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1) , 98
Abstract
Background: This study was devised to assess the performance of anti-ribosomal P (anti-Rib-P) antibodies in the diagnosis of systemic lupus erythematosus (SLE) and the association of these antibodies with the clinical features of SLE.Methods: We used a fluorescence enzyme immunoassay to determine anti-Rib-P levels in an SLE group, a rheumatic disease control (RDC) group (rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis), and a healthy control (HC) group. We also determined anti-Smith antigen (anti-Sm) and anti-double-stranded DNA (anti-dsDNA) antibody levels. Receiver operating characteristic (ROC) curves were constructed and the best cut-off points for positivity were determined. Using regression analysis, the relationship between clinical variables and autoantibody levels was analyzed.Results: In total, 127 patients with SLE, 256 controls with other rheumatic diseases, and 100 HCs were studied. Anti-Rib-P autoantibodies were positive in 18 (14.2%) of the patients with SLE (mean concentration of 30.6 ± 46.9 U/ml) and in 2 patients with RA (0.8% of the RDC group). In addition, 12 patients with SLE (9.4%) were positive for anti-Sm (31.1 ± 40.8 U/ml) and 63 (49.6%) were positive for anti-dsDNA autoantibodies (88.4 ± 88.5 U/ml). When we assessed the 18 patients with SLE who had tested positive for anti-Rib-P, we found that 4 of these were positive for anti-Rib-P only, whereas 12 were positive for anti-Rib-P plus anti-dsDNA, and 2 were positive for all three antibodies. There were no samples positive for anti-Rib-P plus anti-Sm. The specificity, sensitivity, positive likelihood ratio, and negative likelihood ratio of anti-Rib-P for SLE diagnosis were 99.4%, 14.2%, 23.7%, and 0.86%, respectively.Caucasian ethnicity was associated with lower anti-Rib-P antibody levels. No relation was found between anti-Rib-P levels and neuropsychiatric or other clinical features.Conclusions: Anti-Rib-P autoantibodies have high specificity for SLE, and measurement of these might improve the accuracy of SLE diagnosis. In this study, we found that Caucasian ethnicity was associated with lower anti-Rib-P antibody levels.Keywords
This publication has 36 references indexed in Scilit:
- Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2011
- Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptidesJournal of Molecular Medicine, 2010
- Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort studyJournal of Autoimmunity, 2009
- Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodiesArthritis Research & Therapy, 2008
- Technical and clinical evaluation of anti‐ribosomal P protein immunoassaysJournal of Clinical Laboratory Analysis, 2004
- Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodiesAnnals of the Rheumatic Diseases, 2000
- PREVALENCE AND CLINICAL SIGNIFICANCE OF ANTIBODIES TO RIBONUCLEOPROTEINS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN MALAYSIARheumatology, 1996
- Measurement of increases in anti‐double‐stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosusArthritis & Rheumatism, 1990
- Association between Lupus Psychosis and Antiribosomal P Protein AntibodiesNew England Journal of Medicine, 1987
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978